BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T130000
DTEND;TZID=America/New_York:20260512T140000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Translational Paths: Navigating New Bioengineered Models and Clinical Studies in Cardiovascular Research
DESCRIPTION:Transforming a laboratory discovery into a clinical application requires a combination of high-fidelity modeling and a strategic understanding of the translational ecosystem. This roundtable brings together technical innovation and institutional leadership to help researchers navigate this complex journey and will feature two distinct perspectives: Jenn Fang\, Ph.D. (Tulane University) will discuss the launch of the Tulane Center of Excellence in Microphysiological Systems and Nancy K. Sweitzer\, M.D.\, Ph.D. (Washington University in St. Louis) will guide attendees through the essential frameworks for translational impact. This roundtable is designed for scientists at all career stages looking to integrate cutting-edge "on-a-chip" tools with the strategic roadmaps necessary for translational success. A moderated Q&A session will be led by Dr. Pengchun Yu (Oklahoma Medical Research Foundation) and Dr. Skylar King (WashU School of Medicine) from NAVBO's Growth Enrichment Committee (GEC).
X-ALT-DESC;FMTTYPE=text/html:Transforming a laboratory discovery into a clinical application requires a combination of high-fidelity modeling and a strategic understanding of the translational ecosystem. This roundtable brings together technical innovation and institutional leadership to help researchers navigate this complex journey and will feature two distinct perspectives: Jenn Fang\, Ph.D. (Tulane University) will discuss the launch of the Tulane Center of Excellence in Microphysiological Systems and Nancy K. Sweitzer\, M.D.\, Ph.D. (Washington University in St. Louis) will guide attendees through the essential frameworks for translational impact. \;
This roundtable is designed for scientists at all career stages looking to integrate cutting-edge "\;on-a-chip"\; tools with the strategic roadmaps necessary for translational success. A moderated Q&\;A session will be led by Dr. Pengchun Yu (Oklahoma Medical Research Foundation) and Dr. Skylar King (WashU School of Medicine) from NAVBO'\;s Growth Enrichment Committee (GEC).
LOCATION:
UID:e.2142.1443343
SEQUENCE:3
DTSTAMP:20260417T080327Z
URL:https://members.navbo.org/calendar-of-events/Details/translational-paths-navigating-new-bioengineered-models-and-clinical-studies-in-cardiovascular-research-1709587?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR